Cargando…

A simple and available measurement of onco-sEV dsDNA to protein ratio as a potential tumor marker

BACKGROUND: Small extracellular vesicles (sEVs) have great potential as new biomarkers in liquid biopsy. However, due to the limitations of sEVs extraction and component analysis procedures, further clinical applications of sEVs are hampered. Carcinoembryonic antigen (CEA) is a commonly used broad-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yifan, Li, Miao, Zhang, Xiaoshan, Xu, Dongjie, Wu, Jie, Gu, Xinrui, Khan, Adeel, Shen, Han, Li, Zhiyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316596/
https://www.ncbi.nlm.nih.gov/pubmed/37400751
http://dx.doi.org/10.1186/s12885-023-10886-3
Descripción
Sumario:BACKGROUND: Small extracellular vesicles (sEVs) have great potential as new biomarkers in liquid biopsy. However, due to the limitations of sEVs extraction and component analysis procedures, further clinical applications of sEVs are hampered. Carcinoembryonic antigen (CEA) is a commonly used broad-spectrum tumor marker that is strongly expressed in a variety of malignancies. RESULTS: In this study, CEA(+) sEVs were directly separated from serum using immunomagnetic beads, and the nucleic acid to protein ultraviolet absorption ratio (NPr) of CEA(+) sEVs was determined. It was found that the NPr of CEA(+) sEVs in tumor group was higher than that of healthy group. We further analyzed the sEV-derived nucleic acid components using fluorescent staining and found that the concentration ratio of double-stranded DNA to protein (dsDPr) in CEA(+) sEVs was also significantly different between the two groups, with a sensitivity of 100% and a specificity of 41.67% for the diagnosis of pan-cancer. The AUC of dsDPr combined with NPr was 0.87 and the ACU of dsDPr combined with CA242 could reach 0.94, showing good diagnostic performance for pan-cancer. CONCLUSIONS: This study demonstrates that the dsDPr of CEA(+) sEVs can effectively distinguish sEVs derived from tumor patients and healthy individuals, which can be employed as a simple and cost-effective non-invasive screening technology to assist tumor diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10886-3.